DERM

Journey Medical Corporation Common Stock

4.47

USD

+0.17

+3.95%

Nov 06, 15:59 UTC -5

Closed

After-Market

4.49

+0.02

+0.45%

Journey Medical Corporation Common Stock (DERM) Profile

Journey Medical Corporation Common Stock Profile

About

Journey Medical Corporation is a commercial-stage pharmaceutical company. It focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Journey Medical Corporation is based in Scottsdale, Arizona.

Info & Links

CEO

Claude Maraoui

Headquarters

9237 E VIA DE VENTURA BLVD., SUITE 105
SCOTTSDALE, AZ 85258, UNITED STATES

Auditor

KPMG LLP

Share holders

Employees

Journey Medical Corporation Common Stock Statistics

Valuation Measures

Market Capitalization²

126.73M

Enterprise Value

126.56M

Enterprise Value/EBITDA(ttm)

72.61

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.85

Price to Book(mrq)

3.85

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

65.35%

Operating Margin(ttm)

-8.95%

Profit Margin(ttm)

-9.14%

Return on Equity(ttm)

-20.23%

Return on Invested Capital(ttm)

-12.02%

Return on Assets(ttm)

-6.60%

Income Statement

Revenue(ttm)

68.18M

Revenue Per Share(ttm)

2.42

Gross Profit(ttm)

44.62M

EBITDA(ttm)³

1.74M

Net Income Available to Common(ttm)

-6.10M

Diluted EPS(ttm)

-0.22

Share Statistics

Beta (5Y Monthly)

1.14

52-Week Change

-50.93%

S&P 500 52-Week Change

14.38%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

28.22M

Dividend Yield

0.00%

Float⁴

24.12M

% Held by Insiders

14.53%

% Held by Institutions

7.25%

Balance Sheet

Total Cash(mrq)

25.64M

Total Cash Per Share(mrq)

0.91

Total Debt(mrq)

25.47M

Total Debt/Equity(mrq)

79.32%

Current Ratio(mrq)

1.59%

Quick Ratio(mrq)

1.41%

Book Value Per Share(mrq)

1.16

Cash Flow

Operating Cash Flow Per Share(ytd)

0.04

Free Cash Flow(ytd)

1.18M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.